Anika Therapeutics, Inc.
NASDAQ:ANIKMedical - Devices
-$0.06 today
- Market cap
- $182.44M
- Beta
- 0.23
- P/E (TTM)
- -17.3
- EPS (TTM)
- -$0.82
Volume 0.12M
Average 0.11M
ANIK Intangible Assets
Identifiable non-physical assets such as patents, trademarks, licenses, and customer relationships.
Anika Therapeutics, Inc.NASDAQ: ANIK
Intangible Assets · Q1 FY2026 · quarter ended Mar 2026
Intangible assets falls 27.7% from a year ago
Intangible assets stood at $1.65M at the end of Q1 FY2026, down 27.7% from a year earlier and up 0.0% from the prior quarter. Over 3 fiscal years it compounded at -71.9% a year.
Context
- Intangible assets amounted to 0.9% of total assets at the end of Q1 FY2026, down 0.3 pp from a year earlier.
- Intangible assets increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether intangible assets keeps falling in the next quarterly balance sheet after a -27.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Intangible Assets history
USD · from the balance sheet
- Latest · FY2025
- 1.65M USD
- Year-over-year change
- -33.7%
- 4-year CAGR
- -62.4%
| Period | Period end | Intangible Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.65M | -33.7% |
| FY2024 | 2024-12-31 | 2.49M | -3.3% |
| FY2023 | 2023-12-31 | 2.58M | -96.5% |
| FY2022 | 2022-12-31 | 74.6M | -9.4% |
| FY2021 | 2021-12-31 | 82.38M | — |
Intangible Assets vs competitors
How ANIK compares with its peers on the latest reported figures
- ANIK's Mar 2026 intangible assets of $1.65M is the 3rd highest of the 9 companies compared; the peer median is $157.5K.
- Its year-over-year change of -27.7% is the 5th highest of 6, against a peer median of -15.6%.
- Intangible assets amounts to 0.9% of total assets for ANIK, versus a peer median of 0.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $4.96M | -15.6% | -24.6% | 7.5% | |
| Mar 2026 | $1.75M | +66.6% | -15.0% | 2.0% | |
| Mar 2026 | $1.65M | -27.7% | -71.9% | 0.9% | |
| Mar 2026 | $783K | +57.2% | — | 0.4% | |
| Mar 2026 | $210K | -66.7% | -54.9% | 0.6% | |
AVRAnteris Technologies Global Corp. | Mar 2026 | $105K | -26.1% | -52.5% | 0.0% |
| Mar 2026 | $0 | — | — | 0.0% | |
| Apr 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding ANIK) | $157.5K | -15.6% | -38.6% | 0.2% | |
Competitors are the stored peer set for ANIK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 94.39M | 86.33M | 68.74M | 55.63M | 57.48M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 29.84M | 34.63M | 26.36M | 23.59M | 23.69M |
| Inventory | 36.01M | 39.77M | 24.43M | 23.81M | 18.79M |
| Other Current Assets | 0 | 0 | 43.78M | 10.62M | 3.4M |
| Total Current Assets | 168.53M | 169.55M | 163.31M | 113.65M | 103.36M |
| Property, Plant & Equipment (Net) | 68.56M | 78.98M | 65M | 64.68M | 66.26M |
| Goodwill | 7.78M | 7.34M | 7.57M | 7.13M | 8.05M |
| Intangible Assets | 82.38M | 74.6M | 2.58M | 2.49M | 1.65M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 1.45M | 1.49M | 1.18M | 1.28M |
| Other Non-current Assets | 20.29M | 17.22M | 30.69M | 13.62M | 9.67M |
| Total Non-current Assets | 179.01M | 179.58M | 107.32M | 89.09M | 86.91M |
| Total Assets | 347.54M | 349.13M | 270.63M | 202.74M | 190.27M |
| Account Payables | 7.63M | 9.07M | 6.19M | 5.62M | 6.04M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 810K | 1.24M | 63K | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 13.84M | 11.3M | 18.73M | 12.16M | 11.11M |
| Total Current Liabilities | 29.8M | 27.91M | 31.06M | 23.31M | 21.91M |
| Long-term Debt | 0 | 0 | 0 | 0 | 24.2M |
| Deferred Tax Liabilities | 10.16M | 6.44M | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 1.26M | 398K | 1.39M | 1.43M | 701K |
| Total Non-current Liabilities | 30.66M | 35.65M | 27.31M | 25.45M | 24.9M |
| Total Liabilities | 60.45M | 63.57M | 58.37M | 48.75M | 46.81M |
| Common Stock | 144K | 146K | 147K | 144K | 139K |
| Retained Earnings | 225.58M | 210.72M | 128.05M | 71.67M | 60.79M |
| Accumulated OCI | (5.72M) | (6.44M) | (5.94M) | (6.78M) | (4.96M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 287.09M | 285.56M | 212.27M | 153.99M | 143.47M |
| Total Debt | 20.95M | 30.89M | 27.74M | 25.93M | 26.25M |
| Net Debt | (73.43M) | (55.44M) | (41M) | (29.7M) | (31.23M) |
Anika Therapeutics, Inc.
NASDAQ:ANIK
Intrinsic Alpha fair value
Locked
Current Price
$13.62
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.